Type 2 & other diabetes

Effect of an Intermittent Calorie-restricted Diet on Type 2 Diabetes Remission: A Randomized Controlled Trial

J Clin Endocrinol MetabPublished Randomised controlled trial

Primary result · Diabetes remission (HbA1c <48 mmol/mol (<6.5%) for ≥3 months after discontinuing all antidiabetic medications)Result — go to the resultOR for diabetes remission 31.32 95% CI 2.39–121.07

Authors' conclusion

This study demonstrated the clinical efficacy of CMNT in achieving diabetes remission for at least 1 year.

Study context

Population
Adults aged 38–72 years with T2D for 1 to 11 years, body mass index (BMI) 19.1 to 30.4, 66.7% male, on antidiabetic agents and/or insulin
Participants
36 vs 36
Comparison
Chinese Medical Nutrition Therapy vs control
  • Chinese Medical Nutrition Therapy (CMNT)n = 36
  • Controln = 36reference
Primary endpoint
Diabetes remission: stable HbA1c <48 mmol/mol (<6.5%) for ≥3 months after discontinuing all antidiabetic medications
Follow-up
3-month intervention plus 3-month follow-up
Methodological detailsrandomized 1:1
  • Randomized 1:1

Primary result

As reported in the abstract

Diabetes remission (HbA1c <48 mmol/mol (<6.5%) for ≥3 months after discontinuing all antidiabetic medications)

OR for diabetes remission

31.32

95% CI 2.39–121.07

P < 0.0001

Events by treatment group

CMNTvs Control
OR for diabetes remission 31.32 (95% CI 2.39–121.07); P < 0.0001

Secondary outcomes

OutcomeCMNTControl
Body weight reductionMean, kg5.93 (SD 2.47)0.27 (SD 1.43)
Medication costs60.4/month265.1/month
Medication costs — Medication costs lower with CMNT than control
77.22%

Sustained remission · 12-month follow-up

Participants with sustained remission
44.4% (16/36)
Hemoglobin A1c (HbA1c) in sustained remission (SD 0.87)
6.33%

Original publication

Effect of an Intermittent Calorie-restricted Diet on Type 2 Diabetes Remission: A Randomized Controlled Trial. J Clin Endocrinol Metab. Published 14 December 2022. doi:10.1210/clinem/dgac661

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.